S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
Log in

NASDAQ:PAHC - Phibro Animal Health Stock Price, Forecast & News

$25.76
+0.18 (+0.70 %)
(As of 01/23/2020 04:00 PM ET)
Today's Range
$25.06
Now: $25.76
$25.80
50-Day Range
$23.95
MA: $24.89
$26.16
52-Week Range
$20.00
Now: $25.76
$36.98
Volume115,200 shs
Average Volume110,633 shs
Market Capitalization$1.04 billion
P/E Ratio25.51
Dividend Yield1.88%
Beta0.83
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PAHC
CUSIPN/A
Phone201-329-7300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$828 million
Cash Flow$2.24 per share
Book Value$5.34 per share

Profitability

Net Income$54.71 million

Miscellaneous

Employees1,600
Market Cap$1.04 billion
Next Earnings Date2/3/2020 (Confirmed)
OptionableOptionable

Receive PAHC News and Ratings via Email

Sign-up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter.


Phibro Animal Health (NASDAQ:PAHC) Frequently Asked Questions

What is Phibro Animal Health's stock symbol?

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?

Phibro Animal Health announced a quarterly dividend on Monday, November 4th. Shareholders of record on Wednesday, November 27th will be given a dividend of $0.12 per share on Wednesday, December 18th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.86%. The ex-dividend date of this dividend is Tuesday, November 26th. View Phibro Animal Health's Dividend History.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Corp (NASDAQ:PAHC) posted its quarterly earnings data on Monday, November, 4th. The company reported $0.19 EPS for the quarter, missing analysts' consensus estimates of $0.24 by $0.05. The firm earned $190 million during the quarter, compared to analyst estimates of $199.22 million. Phibro Animal Health had a net margin of 4.99% and a return on equity of 25.52%. The company's revenue for the quarter was down 5.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.39 earnings per share. View Phibro Animal Health's Earnings History.

When is Phibro Animal Health's next earnings date?

Phibro Animal Health is scheduled to release their next quarterly earnings announcement on Monday, February 3rd 2020. View Earnings Estimates for Phibro Animal Health.

How can I listen to Phibro Animal Health's earnings call?

Phibro Animal Health will be holding an earnings conference call on Monday, February 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Phibro Animal Health issued on next quarter's earnings?

Phibro Animal Health issued an update on its FY20 earnings guidance on Monday, November, 4th. The company provided earnings per share guidance of $1.08-$1.14 for the period, compared to the Thomson Reuters consensus estimate of $1.12.

What price target have analysts set for PAHC?

5 brokers have issued 12 month price objectives for Phibro Animal Health's stock. Their forecasts range from $18.00 to $42.00. On average, they anticipate Phibro Animal Health's share price to reach $26.60 in the next twelve months. This suggests a possible upside of 3.3% from the stock's current price. View Analyst Price Targets for Phibro Animal Health.

What is the consensus analysts' recommendation for Phibro Animal Health?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 2 sell ratings, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Phibro Animal Health.

Has Phibro Animal Health been receiving favorable news coverage?

Media coverage about PAHC stock has been trending somewhat positive on Thursday, InfoTrie reports. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Phibro Animal Health earned a coverage optimism score of 0.8 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Phibro Animal Health.

Are investors shorting Phibro Animal Health?

Phibro Animal Health saw a increase in short interest in December. As of December 31st, there was short interest totalling 778,200 shares, an increase of 7.1% from the December 15th total of 726,300 shares. Based on an average daily volume of 171,600 shares, the short-interest ratio is currently 4.5 days. Approximately 3.9% of the shares of the company are sold short. View Phibro Animal Health's Current Options Chain.

Who are some of Phibro Animal Health's key competitors?

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Intercept Pharmaceuticals (ICPT), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Zoetis (ZTS), Booking (BKNG), Banco Bradesco (BBD) and Gilead Sciences (GILD).

Who are Phibro Animal Health's key executives?

Phibro Animal Health's management team includes the folowing people:
  • Mr. Jack Clifford Bendheim, Chairman, Pres & CEO (Age 72)
  • Mr. Larry L. Miller, Chief Operating Officer (Age 55)
  • Mr. Dean J. Warras, Pres of Animal Health & Nutrition - North America (Age 50)
  • Mr. Richard G. Johnson, Chief Financial Officer (Age 70)
  • Mr. Thomas G. Dagger, Sr. VP, Gen. Counsel & Corp. Sec. (Age 61)

Who are Phibro Animal Health's major shareholders?

Phibro Animal Health's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Tocqueville Asset Management L.P. (0.70%) and Nisa Investment Advisors LLC (0.07%). Company insiders that own Phibro Animal Health stock include Bfi Co, Llc, Daniel M Bendheim, Dean J Warras, E Thomas Corcoran, Jack Bendheim and Larry Lee Miller. View Institutional Ownership Trends for Phibro Animal Health.

Which institutional investors are buying Phibro Animal Health stock?

PAHC stock was purchased by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC and Tocqueville Asset Management L.P.. View Insider Buying and Selling for Phibro Animal Health.

How do I buy shares of Phibro Animal Health?

Shares of PAHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Phibro Animal Health's stock price today?

One share of PAHC stock can currently be purchased for approximately $25.76.

How big of a company is Phibro Animal Health?

Phibro Animal Health has a market capitalization of $1.04 billion and generates $828 million in revenue each year. The company earns $54.71 million in net income (profit) each year or $1.53 on an earnings per share basis. Phibro Animal Health employs 1,600 workers across the globe.View Additional Information About Phibro Animal Health.

What is Phibro Animal Health's official website?

The official website for Phibro Animal Health is http://www.pahc.com/.

How can I contact Phibro Animal Health?

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The company can be reached via phone at 201-329-7300 or via email at [email protected]


MarketBeat Community Rating for Phibro Animal Health (NASDAQ PAHC)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  274 (Vote Outperform)
Underperform Votes:  333 (Vote Underperform)
Total Votes:  607
MarketBeat's community ratings are surveys of what our community members think about Phibro Animal Health and other stocks. Vote "Outperform" if you believe PAHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PAHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Featured Article: What is Forex?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel